Multi-Peptide Serum Challenge Test Failure B2B Guide

Confirm the test and sample

Verify product code, batch, package, method, inoculum and acceptance criteria. Check whether the sample represents commercial formula and process. A transcription error or unapproved lab prototype can send development in the wrong direction.

Read failure by organism and time

Early bacterial failure suggests a different weakness from late yeast or mold recovery. Review counts, reduction pattern and controls rather than a single pass/fail line. Ask the laboratory about method suitability and neutralization where preservative carryover may distort recovery.

Recalculate every preservative input

List preservative from the base, peptide stocks, botanical blends and fragrances. Confirm active concentrations after dilution. More systems do not necessarily add linearly; pH, partitioning and solubility determine available preservative.

Investigate process and water

Review water quality, vessel sanitation, bulk hold, filling hygiene and package handling. Challenge testing evaluates formula protection under defined conditions; it does not excuse high initial contamination or poor GMP. Check finished-product microbial results and environmental trends.

Change one variable at a time

Screen pH, primary preservative, booster, chelator where appropriate and package route in controlled pilots. Reassess peptide compatibility and safety. A higher preservative level may solve microbiology and create irritation, precipitation or regulatory problems.

Retest the final market system

Repeat the relevant preservation test after formula or package change. ISO 11930 provides a reference approach for evaluating antimicrobial protection of many cosmetic products, but the complete risk assessment and applicable market needs still matter.

Control rework and release

Do not dose a failed commercial batch based on a bench correction unless an approved rework procedure, risk assessment and retest support it. Preserve samples and records. A delayed launch is safer than a formula that passes only because acceptance criteria were relaxed after failure.

Reading the laboratory report with the formulator

Ask for organism-by-organism counts at every time point, method version, acceptance criterion and any deviations. Confirm neutralization and recovery suitability for the formula; an ineffective neutralizer can make preservation look stronger than it is, while poor recovery controls can make results uninterpretable. Compare pH and appearance of the tested sample with the released pilot. Review whether the lab received product in bulk or market pack and how long it waited before inoculation. Then create a written hypothesis ranking formula, raw material, process and package factors. This prevents random booster additions and gives the next pilot a testable reason for each change.

Questions buyers also ask

Why can preserved peptide stocks still fail in serum?

Their preservatives are diluted and may lose availability because of pH, solubility, polymers and the complete formula.

Does an airless package guarantee challenge-test success?

No. Packaging affects risk but does not replace an effective preservation system.

Can a failed batch be reworked with more preservative?

Only under a controlled, justified rework procedure followed by appropriate testing and safety review.

Selected sources

These sources provide context; they do not replace finished-product assessment.

• ISO 11930 antimicrobial protection overview